appengine.ai

Artificial Intelligence | Machine Learning | Natural Language Processing Gero | AI-Driven Drug Discovery and Drug Repurposing


Enterprise, Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification Singapore, Central Region, Singapore

Gero

Artificial Intelligence | Machine Learning | Natural Language Processing


Gero | AI-Driven Drug Discovery and Drug Repurposing

Gero

Pharmaceuticals, Biotechnology, Drug Development, Digital Health, Target Identification


Singapore, Central Region, Singapore

 

Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues.

We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models.

 

N/A

26 to 50

Series A

$2,200,000

N/A

2015

 
 

Pharmaceuticals and Medical Products
Healthcare

N/A

N/A

 
 

N/A

Yes

Active

 
 

   Machine Learning
   Natural Language Processing


Big Data

Big Data

Digital Health Platform

Digital Health Platform

Predictive Analytics

Predictive Analytics


N/A

 

   Software


HTML

HTML

API

API


Neural Networks

Neural Networks

 
 
 Maxim Kholin


Maxim Kholin
Co-Founder

Yuri Deigin


Yuri Deigin
COO

Sergei Filonov


Sergei Filonov
Co-founder and Chief Visionary Officer